| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 75,000 | $282.91 | $21,217,980.00 | -0.4% | +38.5% | +10.4% | |
| Nov 16, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 75,000 | $282.91 | $21,217,980.00 | -0.4% | +38.5% | +10.4% | |
| Nov 15, 2023 | WGS Genedx Holdings Corp. | Meister Keith A.63 | Director, 10% Owner | Sell | 883,742 | $1.29 | $1,140,027.18 | -22.7% | +210.1% | +5615.5% | |
| Nov 14, 2023 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Buy | 5,620 | $178.05 | $1,000,641.00 | +2.9% | +26.6% | +15.8% | |
| Nov 13, 2023 | OPK Opko Health, Inc. | Pfenniger Richard C Jr62 | Director | Buy | 25,000 | $1.30 | $32,491.00 | +2.2% | -18.8% | +25.8% | |
| Nov 13, 2023 | MTD Mettler Toledo International Inc/ | Diggelmann Roland D | Director | Buy | 315 | $1,026.54 | $323,360.10 | +350.0% | +16.8% | +23.7% | |
| Nov 10, 2023 | OPK Opko Health, Inc. | Rubin Steven D68 | Executive Vp-administration | Buy | 10,000 | $1.30 | $13,000.00 | +0.2% | -19.0% | +20.6% | |
| Nov 10, 2023 | OPK Opko Health, Inc. | Hsiao Jane Ph D65 | Vice Chairman &CTO | Buy | 100,000 | $1.27 | $126,659.42 | +0.2% | -19.0% | +20.6% | |
| Nov 10, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,000,000 | $1.27 | $1,266,933.09 | - | -19.0% | +20.6% | |
| Nov 10, 2023 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 435 | $1.25 | $542.92 | -0.2% | +65.8% | +14.2% | |
| Nov 10, 2023 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,765 | $1.25 | $4,699.26 | -0.6% | +65.8% | +14.2% | |
| Nov 10, 2023 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 469 | $1.25 | $585.36 | -0.5% | +65.8% | +14.2% | |
| Nov 10, 2023 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 215 | $1.25 | $268.33 | -1.7% | +65.8% | +14.2% | |
| Nov 10, 2023 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 982 | $1.25 | $1,225.68 | -0.4% | +65.8% | +14.2% | |
| Nov 9, 2023 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 9,128 | $173.48 | $1,583,522.13 | -13.9% | +29.0% | +27.1% | |
| Nov 8, 2023 | WGS Genedx Holdings Corp. | Pfenniger Richard C Jr62 | Director | Buy | 10,000 | $1.49 | $14,889.00 | +91.6% | +159.6% | +5049.3% | |
| Nov 7, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 11,600 | $455.21 | $5,280,456.66 | -0.8% | +20.1% | +21.9% | |
| Nov 3, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $450.82 | $9,016,338.68 | -1.2% | +21.4% | +22.7% | |
| Nov 2, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,000 | $40.25 | $241,501.00 | -1.1% | +62.6% | +206.2% | |
| Nov 1, 2023 | PSNL Personalis, Inc. | Hall Christopher M | President And CEO | Sell | 20,459 | $0.93 | $19,026.87 | -9.1% | +46.8% | +429.4% | |
| Nov 1, 2023 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 30,000 | $15.69 | $470,622.00 | -8.5% | +43.0% | +39.5% | |
| Oct 31, 2023 | WST West Pharmaceutical Services Inc | Witherspoon Charles63 | VP &Treasurer | Sell | 1,190 | $322.37 | $383,623.07 | -21.8% | +16.5% | -1.5% | |
| Oct 23, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,595 | $40.39 | $104,813.09 | -1.2% | +66.4% | +199.3% | |
| Oct 23, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,940 | $40.40 | $159,194.75 | -2.0% | +66.4% | +199.3% | |
| Oct 23, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 803 | $40.39 | $32,433.49 | -0.4% | +66.4% | +199.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.